{"entity":{"id":"ilbawi-andre","kind":"person","name":"André Ilbawi","aka":[],"tldr":"The WHO's lead on cancer control, steering the cervical cancer elimination and global breast and childhood cancer initiatives.","summary":"André Ilbawi is a surgical oncologist and the Technical Lead for Cancer Control at the World Health Organization, working with the International Agency for Research on Cancer. He steers the WHO's cervical cancer elimination strategy, the Global Breast Cancer Initiative and the Global Initiative for Childhood Cancer, with a focus on cancer control policy, global health and access to medicines. His publications include a global analysis of national cancer control plans, a review of the growing burden, rising costs and unequal access in global cancer control, and a modelling study of the mortality impact of meeting the WHO cervical cancer elimination targets in low-income and lower-middle-income countries. His work connects HPV vaccination, screening and treatment into national programmes.","asOf":"2026-09-08","links":[{"label":"WHO cancer","url":"https://www.who.int/health-topics/cancer"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ilbawi%20AM%5BAuthor%5D%20WHO%20cancer"}],"tags":[],"related":[],"cancers":["cervical","breast-hr-positive"],"sections":[],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":["iarc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Technical Lead for Cancer Control, World Health Organization","specialisms":["Cancer control policy","Global health","Surgical oncology","Access to medicines"],"profiles":[{"label":"WHO cancer","url":"https://www.who.int/health-topics/cancer"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ilbawi%20AM%5BAuthor%5D%20WHO%20cancer"}],"papers":[{"title":"National cancer control plans: a global analysis","journal":"The Lancet Oncology","year":2018,"doi":"10.1016/s1470-2045(18)30681-8"},{"title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","journal":"ESMO Open","year":2018,"doi":"10.1136/esmoopen-2017-000285"},{"title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","journal":"The Lancet","year":2020,"doi":"10.1016/s0140-6736(20)30157-4"}]},"route":"/people/ilbawi-andre/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"institution":[{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"},{"id":"who","kind":"institution","name":"World Health Organization Cancer Programme","route":"/institutions/who/"}],"idea":[{"id":"idea-tr1-lmic-sites-in-pivotal-trials","kind":"idea","name":"Pivotal trials include sites in Africa, South Asia and Latin America, sponsor-funded","route":"/ideas/idea-tr1-lmic-sites-in-pivotal-trials/"}]}}